Table 2 Univariate logistic regression model
From: Assessing clinical trial failure risk factors and reasons in gastric cancer
Covariates | Odds ratio | 95% CI | P-value |
|---|---|---|---|
Phase | |||
Phase II | Reference | ||
Phase III | 0.76 | (0.36, 1.64) | 0.491 |
Treatment | |||
Drug | Reference | ||
Device | 1.21 | (0.41, 3.61) | 0.736 |
Genetic | 0.91 | (0.40, 2.03) | 0.809 |
Radiation | Omit | ||
Other | Omit | ||
Sponsor | |||
Other | Reference | ||
NIH | 0.80 | (0.18, 3.58) | 0.771 |
Industry | 1.08 | (0.57, 2.06) | 0.815 |
Multi-centre | |||
No | Reference | ||
Yes | 1.77 | (0.92, 3.39) | 0.088 |
Multi-country | |||
No | Reference | ||
Yes | 1.75 | (0.88, 3.48) | 0.110 |
Anticipated accrual | 0.78 | (0.58, 1.05) | 0.099 |